COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER

NCT05692024 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer
Coffee
Gastrointestinal Microbiome
Stenosis
Fibrosis, Liver
Ultrasound Elastography
Proton Magnetic Resonance Spectroscopy

Interventions

DRUG: Nestlé NESCAFÉ® TASTER'S CHOICE® House Blend capsule.
DRUG: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]
[object Object]